These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9309490)

  • 1. Age of onset and brain atrophy in Alzheimer's disease.
    Woo JI; Kim JH; Lee JH
    Int Psychogeriatr; 1997 Jun; 9(2):183-96. PubMed ID: 9309490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Qualitative magnetic resonance imaging findings in geriatric depression. Possible link between later-onset depression and Alzheimer's disease?
    Greenwald BS; Kramer-Ginsberg E; Bogerts B; Ashtari M; Aupperle P; Wu H; Allen L; Zeman D; Patel M
    Psychol Med; 1997 Mar; 27(2):421-31. PubMed ID: 9089834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computerised tomography in Alzheimer's disease. Methods of scan analysis, comparison with normal controls, and clinical/radiological associations.
    Burns A; Jacoby R; Philpot M; Levy R
    Br J Psychiatry; 1991 Nov; 159():609-14. PubMed ID: 1756335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and APO E4 medial temporal lobe dementias. The Oxford Project to Investigate Memory and Aging.
    Jobst KA; Barnetson LP; Shepstone BJ
    Int Psychogeriatr; 1997; 9 Suppl 1():191-222; discussion 247-52. PubMed ID: 9447442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different patterns of gray matter atrophy in early- and late-onset Alzheimer's disease.
    Möller C; Vrenken H; Jiskoot L; Versteeg A; Barkhof F; Scheltens P; van der Flier WM
    Neurobiol Aging; 2013 Aug; 34(8):2014-22. PubMed ID: 23561509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral volume loss, cognitive deficit and neuropsychological performance: comparative measures of brain atrophy: I. Dementia.
    Bigler ED; Neeley ES; Miller MJ; Tate DF; Rice SA; Cleavinger H; Wolfson L; Tschanz J; Welsh-Bohmer K
    J Int Neuropsychol Soc; 2004 May; 10(3):442-52. PubMed ID: 15147601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortical variability and asymmetry in normal aging and Alzheimer's disease.
    Thompson PM; Moussai J; Zohoori S; Goldkorn A; Khan AA; Mega MS; Small GW; Cummings JL; Toga AW
    Cereb Cortex; 1998 Sep; 8(6):492-509. PubMed ID: 9758213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrophy of the hippocampus, parietal cortex, and insula in Alzheimer's disease: a volumetric magnetic resonance imaging study.
    Foundas AL; Leonard CM; Mahoney SM; Agee OF; Heilman KM
    Neuropsychiatry Neuropsychol Behav Neurol; 1997 Apr; 10(2):81-9. PubMed ID: 9150507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of global brain atrophy in Alzheimer's disease with unsupervised segmentation of spin-echo MRI studies.
    Brunetti A; Postiglione A; Tedeschi E; Ciarmiello A; Quarantelli M; Covelli EM; Milan G; Larobina M; Soricelli A; Sodano A; Alfano B
    J Magn Reson Imaging; 2000 Mar; 11(3):260-6. PubMed ID: 10739557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical presentation of Moroccan cases with Alzheimer's disease].
    El Kadmiri N; Zaid Y; Hamzi K; Nadifi S; Slassi I; El Moutawakil B
    Encephale; 2014 Dec; 40(6):481-6. PubMed ID: 25127896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and Apo E4 in medial temporal lobe dementias. Oxford Project to Investigate Memory and Aging.
    Jobst KA; Barnetson LP; Shepstone BJ
    Int Psychogeriatr; 1998 Sep; 10(3):271-302. PubMed ID: 9785148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. White matter hyperintensities are significantly associated with cortical atrophy in Alzheimer's disease.
    Capizzano AA; Ación L; Bekinschtein T; Furman M; Gomila H; Martínez A; Mizrahi R; Starkstein SE
    J Neurol Neurosurg Psychiatry; 2004 Jun; 75(6):822-7. PubMed ID: 15145992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serial brain MRI at 3-6 month intervals as a surrogate marker for Alzheimer's disease.
    Bradley KM; Bydder GM; Budge MM; Hajnal JV; White SJ; Ripley BD; Smith AD
    Br J Radiol; 2002 Jun; 75(894):506-13. PubMed ID: 12124237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative magnetic resonance imaging differences between Alzheimer disease with and without subcortical lacunes.
    Hsu YY; Schuff N; Amend DL; Du AT; Norman D; Chui HC; Jagust WJ; Weiner MW
    Alzheimer Dis Assoc Disord; 2002; 16(2):58-64. PubMed ID: 12040300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The differentiation of depression from dementia by temporal lobe magnetic resonance imaging.
    O'Brien JT; Desmond P; Ames D; Schweitzer I; Tuckwell V; Tress B
    Psychol Med; 1994 Aug; 24(3):633-40. PubMed ID: 7991745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MR image-based measurement of rates of change in volumes of brain structures. Part II: application to a study of Alzheimer's disease and normal aging.
    Wang D; Chalk JB; Rose SE; de Zubicaray G; Cowin G; Galloway GJ; Barnes D; Spooner D; Doddrell DM; Semple J
    Magn Reson Imaging; 2002 Jan; 20(1):41-8. PubMed ID: 11973028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive decline strongly correlates with cortical atrophy in Alzheimer's dementia.
    Mouton PR; Martin LJ; Calhoun ME; Dal Forno G; Price DL
    Neurobiol Aging; 1998; 19(5):371-7. PubMed ID: 9880038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease.
    Kuhl DE; Minoshima S; Fessler JA; Frey KA; Foster NL; Ficaro EP; Wieland DM; Koeppe RA
    Ann Neurol; 1996 Sep; 40(3):399-410. PubMed ID: 8797529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. White matter lesions on magnetic resonance imaging in clinically diagnosed Alzheimer's disease. Evidence for heterogeneity.
    Scheltens P; Barkhof F; Valk J; Algra PR; van der Hoop RG; Nauta J; Wolters EC
    Brain; 1992 Jun; 115 ( Pt 3)():735-48. PubMed ID: 1628199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance findings in patients with early-onset Alzheimer's disease.
    McDonald WM; Krishnan KR; Doraiswamy PM; Figiel GS; Husain MM; Boyko OB; Heyman A
    Biol Psychiatry; 1991 Apr; 29(8):799-810. PubMed ID: 2054453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.